Data for (Study ST002406)
(Analysis AN003923)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 |
|---|---|---|---|---|---|---|---|---|---|
| 1,1^-diindolylmethane | 1.0125 | 0.9231 | 0.8998 | 1.1722 | 0.7071 | 0.6368 | 1.2009 | 1.1966 | 1.1446 |
| 4-methoxyglucobrassicin | 1.5782 | 2.1607 | 1.1397 | 0.3182 | 0.5421 | 0.3944 | 0.6771 | 0.6710 | 0.3106 |
| Brassicanal A | 1.8604 | 1.6620 | 1.5594 | 0.4212 | 0.4421 | 0.3446 | 0.6207 | 0.2959 | 0.5024 |
| Brassicanate A | 1.2296 | 1.0136 | 1.0486 | 1.0420 | 0.8993 | 0.9096 | 1.0654 | 0.4789 | 1.1661 |
| Glucobrassicin | 1.0453 | 2.3971 | 1.2496 | 0.3808 | 0.8297 | 0.3228 | 0.5683 | 0.6002 | 0.5531 |
| Gluconasturtiin | 0.7747 | 1.2288 | 0.9264 | 0.8177 | 2.9650 | 1.2503 | 0.5300 | 0.7460 | 0.4621 |
| Indole-3-carboxaldehyde | 1.2960 | 1.2633 | 1.0502 | 0.7550 | 0.7591 | 0.6600 | 0.9059 | 1.0203 | 0.8119 |
| Neoglucobrassicin | 1.0433 | 1.5218 | 1.0639 | 0.6472 | 0.7345 | 0.5402 | 1.0859 | 0.9860 | 0.8081 |
| Rutalexin | 1.5728 | 2.1204 | 2.2235 | 0.0820 | 0.1693 | 0.6825 | 0.1217 | 0.0600 | 0.0141 |
| Syringin | 1.6350 | 1.3706 | 1.6706 | 1.0288 | 0.8740 | 1.1172 | 0.2042 | 0.3732 | 0.1743 |
Factors:
| F1 | Developmental stage (DPI):day 14 | Silicon treatment [g]:0.0 |
| F2 | Developmental stage (DPI):day 14 | Silicon treatment [g]:0.5 |
| F3 | Developmental stage (DPI):day 14 | Silicon treatment [g]:1.0 |
| F4 | Developmental stage (DPI):day 21 | Silicon treatment [g]:0.0 |
| F5 | Developmental stage (DPI):day 21 | Silicon treatment [g]:0.5 |
| F6 | Developmental stage (DPI):day 21 | Silicon treatment [g]:1.0 |
| F7 | Developmental stage (DPI):day 7 | Silicon treatment [g]:0.0 |
| F8 | Developmental stage (DPI):day 7 | Silicon treatment [g]:0.5 |
| F9 | Developmental stage (DPI):day 7 | Silicon treatment [g]:1.0 |
